Here’s a brief summary of the PR Newswire article about LIV Process:
Philadelphia-based biotech LIV Process unveiled a patented “microbial visualization” technology at IDWeek 2025 that makes dangerous pathogens like Clostridioides difficile (C. diff) visible on surfaces without a microscope. The proprietary solution binds to resilient spores and fluoresces under a specific light, helping hospitals see and verify where contamination remains after cleaning. This gives frontline staff real-time feedback to improve infection prevention. The company is working with major health systems to validate and expand use, and sees future applications beyond acute care. (prnewswire.com)